{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:41:57Z","timestamp":1777300917909,"version":"3.51.4"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A stability-indicating reverse phase high-performance liquid chromatography method was developed and validated for simultaneous quantification of apremilast (APL) and betamethasone dipropionate (BD) in bulk as well as drug loaded microsponges. Various mobile phase systems were screened to check the system suitability followed by force degradation analysis to determine APL and BD stability under varying stress conditions. A central composite design model was used to optimize the column temperature and flow rate using Design Expert\u00ae (9.0.1). One factor at a time approach with five independent factors were used to validate the robustness of the method. Finally, APL and BD were precisely and accurately quantified from drug loaded microsponges using the validated method. A favorable separation of APL and BD was obtained on a Phenomenex\u00ae Luna C18 column using a mixture of 50\u00a0mM phosphate buffer containing 0.1% triethylamine (pH\u00a06.1) and acetonitrile (60:40%v\/v) as mobile phase. Both the drugs were found to be stable when exposed to stressors such as heat-, light-, alkali-, acid- and peroxide-induced degradation. The calibration curves were found to be linear with appreciable limit of detection and limit of quantification. Recovery and percentage relative standard deviation of peak areas for APL and BD were found to be &amp;lt;\u20092.0% and 99\u2013100% in bulk drug solution and\u00a0&amp;lt;2.0% and 99\u2013103% in microsponge formulation, respectively. Statistical analysis using analysis of variance indicated that the model was significant (P\u00a0&amp;lt;\u00a00.001). Hence, the developed method can be effectively used to quantify APL and BD, both in bulk as well as microsponge formulations.<\/jats:p>","DOI":"10.1093\/chromsci\/bmab016","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T12:10:29Z","timestamp":1611663029000},"page":"928-940","source":"Crossref","is-referenced-by-count":13,"title":["Simultaneous Estimation of Apremilast and Betamethasone Dipropionate in Microsponge-Based Topical Formulation using a Stability Indicating RP-HPLC Method: A Quality-by-Design Approach"],"prefix":"10.1093","volume":"59","author":[{"given":"Prashansha","family":"Mullick","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi District, Karnataka State, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana P","family":"Mutalik","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi District, Karnataka State, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswathi R","family":"Hegde","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi District, Karnataka State, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijeet","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi District, Karnataka State, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P C","family":"Jagadish","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi District, Karnataka State, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvarna G","family":"Kini","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi District, Karnataka State, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanyog","family":"Jain","sequence":"additional","affiliation":[{"name":"Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar (Mohali), Punjab 160062, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0642-1928","authenticated-orcid":false,"given":"Srinivas","family":"Mutalik","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi District, Karnataka State, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"2021110306244290800_ref1","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/chromsci\/bmw062","article-title":"Development and validation of a stability-indicating RP-HPLC method by a statistical optimization process for the quantification of asenapine maleate in lipidic nanoformulations","volume":"54","author":"Managuli","year":"2016","journal-title":"Journal of Chromatographic Science"},{"key":"2021110306244290800_ref2","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.13040\/IJPSR.0975-8232.7(7).2756-61","article-title":"A new era in topical formulations\u2013microsponge drug delivery system","volume":"7","author":"Avhad","year":"2016","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"key":"2021110306244290800_ref3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.22270\/jddt.v8i5.1885","article-title":"Innovative and novel strategy: Microsponges for topical drug delivery","volume":"8","author":"Jyoti","year":"2018","journal-title":"Journal of Drug Delivery and Therapeutics"},{"key":"2021110306244290800_ref4","first-page":"1097","article-title":"Microsponge delivery system: An updated review, current status and future prospects","volume":"2","author":"Jadhav","year":"2013","journal-title":"Journal of Science Innovative Researc JSIR"},{"key":"2021110306244290800_ref5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40005-016-0230-7","article-title":"Formulation and evaluation of microsponge gel for topical delivery of fluconazole for fungal therapy","volume":"46","author":"Patel","year":"2016","journal-title":"Journal of Pharmaceutical Investigation"},{"key":"2021110306244290800_ref6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/2455-3972.196166","article-title":"Apremilast: A dermatologic perspective","volume":"2","author":"Bubna","year":"2016","journal-title":"Indian Journal of Drugs Dermatology"},{"issue":"1","key":"2021110306244290800_ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/idoj.IDOJ_437_18","article-title":"Apremilast in psoriasis and beyond: Big hopes on a small molecule","volume":"10","author":"Afra","year":"2019","journal-title":"Indian Dermatology Online Journal"},{"key":"2021110306244290800_ref8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1517\/14656566.2015.1076794","article-title":"Apremilast for the treatment of psoriasis","volume":"16","author":"Chimenti","year":"2015","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"2021110306244290800_ref9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1023\/a:1018946924585","article-title":"Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin","volume":"16","author":"Gysler","year":"1999","journal-title":"Pharmaceutical Research"},{"issue":"5","key":"2021110306244290800_ref10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/archderm.1976.01630290031006","article-title":"Betamethasone dipropionate cream for the treatment of psoriasis: A collaborative evaluation","volume":"112","author":"Charney","year":"1976","journal-title":"Archives of Dermatology"},{"issue":"3","key":"2021110306244290800_ref11","first-page":"725","article-title":"Treatment of psoriasis: An algorithm-based approach for primary care physicians","volume":"61","author":"Pardasani","year":"2000","journal-title":"American Family Physician"},{"key":"2021110306244290800_ref12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3109\/00498254.2011.604745","article-title":"Disposition, metabolism and mass balance of [14C] apremilast following oral administration","volume":"41","author":"Hoffmann","year":"2011","journal-title":"Xenobiotica"},{"key":"2021110306244290800_ref13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jps.2600841215","article-title":"Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent","volume":"84","author":"Kubota","year":"1995","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"2021110306244290800_ref14","first-page":"552","article-title":"Design and characterization of apremilast loaded emulgel for topical treatment","volume":"8","author":"Ganarajan","year":"2018","journal-title":"IJPBS"},{"key":"2021110306244290800_ref15","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2147\/IJN.S195048","article-title":"Preparation of sustained release apremilast-loaded PLGA nanoparticles: In vitro characterization and in vivo pharmacokinetic study in rats","volume":"14","author":"Anwer","year":"2019","journal-title":"International Journal of Nanomedicine"},{"issue":"12","key":"2021110306244290800_ref16","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1517\/17425247.2014.938634","article-title":"Solid lipid nanoparticles-loaded topical gel containing combination drugs: An approach to offset psoriasis","volume":"11","author":"Sonawane","year":"2014","journal-title":"Expert Opinion on Drug Delivery"},{"key":"2021110306244290800_ref17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s13346-018-0480-1","article-title":"Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: Fabrication, characterisation, in vitro release kinetics, and dermal targeting","volume":"9","author":"Pandey","year":"2019","journal-title":"Drug Delivery and Translational Research"},{"issue":"1","key":"2021110306244290800_ref18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3762\/bxiv.2020.7.v1","article-title":"Formulation, optimization and in vitro evaluation of nanostructured lipid carriers for topical delivery of apremilast","volume":"2020","author":"Madan","year":"2020","journal-title":"Beilstein Archives"},{"issue":"2","key":"2021110306244290800_ref19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajps.2015.07.005","article-title":"Development of a topical ointment of betamethasone dipropionate loaded nanostructured lipid carrier","volume":"11","author":"Kong","year":"2016","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"2021110306244290800_ref20","first-page":"56","article-title":"Design of experiments for analytical method development and validation","volume":"27","author":"Little","year":"2014","journal-title":"Bio Pharm International"},{"key":"2021110306244290800_ref21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1691\/ph.2016.6095","article-title":"A guide for using experimental design in chromatographic method development: Applied to the analysis of selected anti-diabetic pharmaceutical combinations","volume":"71","author":"Ayoub","year":"2016","journal-title":"Die Pharmazie"},{"key":"2021110306244290800_ref22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4236\/ajac.2014.517130","article-title":"Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments","volume":"72","author":"Murthy","year":"2013","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"2021110306244290800_ref23","first-page":"61","article-title":"Spectrophotometric Determination of Corticosteroids and Its Application in Pharmaceutical Formulation","volume":"7","author":"Singh","year":"2008","journal-title":"Iranian Journal of Pharmacology Therapeutics"},{"key":"2021110306244290800_ref24","first-page":"47","article-title":"Development and validation of stability-indicating UV spectrophotometric method for determination of Apremilast in bulk and pharmaceutical dosage form","volume":"5","author":"Ravisankar","year":"2017","journal-title":"Indian Journal of Research in Pharmacy and Biotechnology"},{"key":"2021110306244290800_ref25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0731-7085(01)00667-7","volume":"28","author":"Wang","year":"2002","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"2021110306244290800_ref26","first-page":"1493","article-title":"Development and validation of stability indicating RP-HPLC method for the estimation of apremilast by forced degradation studies","volume":"6","author":"Lonkar","year":"2017","journal-title":"Journal of Pharmacy & Pharmaceutical Sciences"},{"key":"2021110306244290800_ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s40543-019-0170-8","article-title":"Design of experiment avenue for development and validation of RP-HPLC-PDA method for determination of apremilast in bulk and in in-house tablet formulation","volume":"10","author":"Chaudhari","year":"2019","journal-title":"Journal of Analytical Science and Technology"},{"key":"2021110306244290800_ref28","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/jssc.201900538","article-title":"Stability indicating liquid chromatographic method for simultaneous quantification of betamethasone valerate and tazarotene in in vitro and ex vivo studies of complex nanoformulation","volume":"42","author":"Rapalli","year":"2019","journal-title":"Journal of Separation Science"},{"key":"2021110306244290800_ref29","first-page":"326","volume":"29","author":"Deng","year":"2008","journal-title":"Academic Journal of Second Military Medical University"},{"key":"2021110306244290800_ref30","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/chromsci\/bmw072","article-title":"Determination of apremilast in rat plasma by UPLC\u2013MS-MS and its application to a pharmacokinetic study","volume":"54","author":"L-g","year":"2016","journal-title":"Journal of Chromatographic Science"},{"key":"2021110306244290800_ref31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2153-2435.1000113","article-title":"Simultaneous HPLC analysis of betamethasone and clotrimazole in cream formulations, pharm","volume":"01","author":"Manassra","year":"2010","journal-title":"Analytical Acta"},{"key":"2021110306244290800_ref32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/03639049809085657","article-title":"Determination of betamethasone dipropionate and salicylic acid in pharmaceutical preparations by high-performance liquid chromatography","volume":"24","author":"Kedor-Hackmann","year":"1998","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"2021110306244290800_ref33","article-title":"Development and validation of a stability-indicating NP-HPLC method for simultaneous determination of betamethasone dipropionate and calcipotriene in topical dosage form; Archives of Applied Science Research","author":"Roy","year":"2013"},{"key":"2021110306244290800_ref34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0250-474X.103840","article-title":"Development and validation of stability-indicating HPLC method for betamethoasone dipropionate and related substances in topical formulation","volume":"74","author":"Vairale","year":"2012","journal-title":"Indian Journal of Pharmaceutical Sciences"},{"key":"2021110306244290800_ref35","article-title":"Validation of analytical procedures: Definitions and terminology methodology, adopted in, Geneva","author":"International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use","year":"1996"},{"key":"2021110306244290800_ref36","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/583090","article-title":"Optimization (central composite design) and validation of HPLC method for investigation of emtricitabine loaded poly (lactic-co-glycolic acid) nanoparticles: In vitro drug release and in vivo pharmacokinetic studies","volume":"2014","author":"Singh","year":"2014","journal-title":"Scientific World Journal"},{"key":"2021110306244290800_ref37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2174\/1573412913666171006152604","article-title":"Full factorial experimental design for development and validation of a RP-HPLC method for estimation of letrozole in nanoformulations","volume":"14","author":"Hegde","year":"2017","journal-title":"Current Pharmaceutical Analysis"},{"key":"2021110306244290800_ref38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3329\/dujps.v16i2.35248","article-title":"Optimization of HPLC using central composite design for determination of curcumin and demethoxycurcumin in tablet dosage form","volume":"16","author":"Siregar","year":"2017","journal-title":"Dhaka University of Journal of Pharmaceutical Science"},{"key":"2021110306244290800_ref39","first-page":"6144","article-title":"Optimization of disodium edetate topical gel using central composite design and evaluation for external radioactive decontamination","volume":"42","author":"Kamboj","year":"2012","journal-title":"Elixir Pharmaceuticals"},{"key":"2021110306244290800_ref40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/16583655.2018.1548748","article-title":"Development and validation of HPLC method for simultaneous estimation of rifampicin and ofloxacin using experimental design","volume":"13","author":"Shah","year":"2019","journal-title":"Journal of Taibah University Science"},{"key":"2021110306244290800_ref41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7324\/JAPS.2012.2322","article-title":"Stability testing of pharmaceutical products","volume":"2","author":"Bajaj","year":"2012","journal-title":"Journal of Applied Pharmaceutical Science"},{"key":"2021110306244290800_ref42","first-page":"238","article-title":"Forced degradation studies for drug substances and drug products-scientific and regulatory considerations","volume":"7","author":"Rawat","year":"2015","journal-title":"Journal of Pharmaceutical Sciences and Research"},{"key":"2021110306244290800_ref43","first-page":"56","article-title":"Forced degradation as an integral part of HPLC stability-indicating method development","volume":"10","author":"Ngwa","year":"2010","journal-title":"Drug Delivery Technology"},{"key":"2021110306244290800_ref44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4172\/1948-5956.1000433","article-title":"Preparation and evaluation of 5-fluorouracil loaded microsponges for treatment of colon cancer","volume":"09","author":"Othman","year":"2017","journal-title":"Journal of Cancer Science and Therapy"},{"issue":"29","key":"2021110306244290800_ref45","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1016\/j.jchromb.2009.08.039","article-title":"Development and validation of a reversed-phase high-performance liquid chromatographic method for quantification of peptide dendrimers in human skin permeation experiments","volume":"877","author":"Mutalik","year":"2009","journal-title":"Journal of Chromatography B"},{"key":"2021110306244290800_ref46","first-page":"1","article-title":"Design of experiment based optimized RP-HPLC method for simultaneous estimation of amlodipine and valsartan in bulk and tablet formulations","volume":"2","author":"S","year":"2015","journal-title":"Austin Journal of Analytical and Pharmaceutical Chemistry"},{"key":"2021110306244290800_ref47","first-page":"38","article-title":"Development and validation of RP-HPLC-PDA method for estimation of mometasone furoate, salicylic acid, methyl paraben and propyl paraben in combined topical formulation by using design of experiment","volume":"1","author":"Choudhari","year":"2015","journal-title":"Research and Review Journal of Pharmaceutical Quality Assurance"},{"key":"2021110306244290800_ref48","volume-title":"Stability testing of new drug substances and products","author":"ICH Q1A (R2). Stability testing guidelines","year":"2003"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/59\/10\/928\/41001653\/bmab016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/59\/10\/928\/41001653\/bmab016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T06:29:19Z","timestamp":1635920959000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/59\/10\/928\/6146602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,10,29]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmab016","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,2,23]]}}}